4th World Companion Diagnostics Summit November 28, 2011

The World Companion Diagnostics Summit highlights the latest approaches for stratifying patient populations with companion diagnostics and how to deliver better, safer drugs to market with this approach. The event will discuss how to turn predictive biomarkers into robust diagnostic tests with a focus on topics including the development, approval and commercialization of companion diagnostics; translating treatment stratification markers from bench to bedside; clinical validation to commercialization; and prospective and retrospective biomarker development.

Brandon Higgs will present “Identification of a critical patient selection biomarker associated with the luminal-B breast cancer subtype.” MedImmune is a sponsor.